We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+2.48%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.7B
AUM Growth
-$392M
(-1.7%)
Cap. Flow
-$683M
Cap. Flow
% of AUM
-3.01%
Top 10 Holdings %
Top 10 Hldgs %
13.52%
Holding
1,954
New
218
Increased
445
Reduced
978
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Weyerhaeuser
WY
|
+$41.7M |
| 3 |
Mondelez International
MDLZ
|
+$34M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$33.6M |
| 5 |
Lazard
LAZ
|
+$28.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$96.8M |
| 2 |
HCA Healthcare
HCA
|
+$70.3M |
| 3 |
HP
HPQ
|
+$51.1M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$49.2M |
| 5 |
T. Rowe Price
TROW
|
+$47.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.91% |
| 2 | Technology | 14.75% |
| 3 | Healthcare | 14.19% |
| 4 | Industrials | 9.98% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDLI
801
DELISTED
PDL BioPharma, Inc.
PDLI
| $989K | ﹤0.01% |
140,700
+6,300
| +5% | +$45.6K |
|
|
FARO
802
DELISTED
Faro Technologies
FARO
| $987K | ﹤0.01% |
15,900
-400
| -2% | -$22.9K |
|
803
WesBanco
WSBC
$3.95B
| $974K | ﹤0.01% |
29,900
+3,600
| +14% | +$117K |
|
804
Advanced Energy
AEIS
$12.2B
| $967K | ﹤0.01% |
+37,700
| New | +$959K |
|
805
ESCO Technologies
ESE
$8.49B
| $966K | ﹤0.01% |
24,800
-1,200
| -5% | -$45K |
|
806
Agios Pharmaceuticals
AGIO
$2.16B
| $961K | ﹤0.01% |
10,200
-300
| -3% | -$33.6K |
|
|
KERX
807
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $961K | ﹤0.01% |
75,500
+900
| +1% | +$11.6K |
|
808
The Ensign Group
ENSG
$10.1B
| $960K | ﹤0.01% |
43,829
| – | – |
|
|
NP
809
DELISTED
Neenah, Inc. Common Stock
NP
| $956K | ﹤0.01% |
15,300
-600
| -4% | -$35.9K |
|
810
DexCom
DXCM
$27.6B
| $953K | ﹤0.01% |
61,200
-84,400
| -58% | -$1.28M |
|
811
Essent Group
ESNT
$6.06B
| $951K | ﹤0.01% |
39,800
+15,800
| +66% | +$379K |
|
|
SRCI
812
DELISTED
SRC Energy Inc
SRCI
| $950K | ﹤0.01% |
80,200
+7,600
| +10% | +$90.1K |
|
|
BKS
813
DELISTED
Barnes & Noble
BKS
| $950K | ﹤0.01% |
61,040
-305
| -0.5% | -$4.79K |
|
|
SYKE
814
DELISTED
SYKES Enterprises Inc
SYKE
| $949K | ﹤0.01% |
38,200
-1,000
| -3% | -$23.5K |
|
815
Acco Brands
ACCO
$369M
| $947K | ﹤0.01% |
114,000
+7,000
| +7% | +$55.6K |
|
816
ArcBest
ARCB
$3.44B
| $947K | ﹤0.01% |
25,000
+2,500
| +11% | +$101K |
|
817
Shutterstock
SSTK
$205M
| $947K | ﹤0.01% |
13,800
-300
| -2% | -$18.2K |
|
|
HA
818
DELISTED
Hawaiian Holdings, Inc.
HA
| $947K | ﹤0.01% |
43,000
+2,100
| +5% | +$44.7K |
|
819
Sonic Automotive
SAH
$3.15B
| $946K | ﹤0.01% |
38,000
+1,800
| +5% | +$45.5K |
|
820
Quaker Houghton
KWR
$2.63B
| $942K | ﹤0.01% |
11,000
-300
| -3% | -$25.1K |
|
|
CLNY
821
DELISTED
Colony Capital, Inc.
CLNY
| $940K | ﹤0.01% |
36,300
-500
| -1% | -$12.5K |
|
822
Haemonetics
HAE
$3.58B
| $935K | ﹤0.01% |
20,815
+18,315
| +733% | +$766K |
|
823
Qualys
QLYS
$4.84B
| $934K | ﹤0.01% |
20,100
-3,200
| -14% | -$137K |
|
|
BGG
824
DELISTED
Briggs & Stratton Corp.
BGG
| $934K | ﹤0.01% |
45,500
-200
| -0.4% | -$3.94K |
|
825
Repligen
RGEN
$7.44B
| $932K | ﹤0.01% |
30,700
-8,900
| -22% | -$231K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q1 2015 Portfolio in Review
As of Q1 2015, STRS Ohio held 1,954 positions worth $22.7B, down 1.7% from $23.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
STRS Ohio withdrew a net $683M in Q1 2015, closing 152 positions and reducing 978 holdings. Its most notable exit was Allergan Inc, an estimated $96.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Technology and Healthcare.
Against the trend, STRS Ohio opened a new position in Lazard worth $30.5M.
- STRS Ohio's largest Q1 2015 buy was Lazard: 580,430 shares worth $30.5M.
- STRS Ohio added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- STRS Ohio's biggest Q1 2015 reduction was HCA Healthcare, cutting an estimated $70.3M.
- STRS Ohio fully exited Allergan Inc in Q1 2015, selling an estimated $96.8M.
- STRS Ohio's ten largest holdings make up 14% of its $22.7B portfolio in Q1 2015.
- STRS Ohio opened 218 new positions and closed 152 in Q1 2015.
- STRS Ohio's portfolio value fell 1.7% quarter-over-quarter to $22.7B.
Based on STRS Ohio's 13F filing for Q1 2015, filed 21 Apr 2015.